Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 4,200
- Price
- $36.13
- Value
- $151,763
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•25 filings
NGNE
Neurogene Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$1,133,592
4 distinct insiders
Highlighted alerts
0
17 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get NGNE insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
NGNE overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
35
Raw transactions
Everything returned by the filing
17
Voluntary view
P/S trades after deterministic checks
18
Administrative noise
Stored, never alerted
17
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 756
- Price
- $25.32
- Footnotes
- 2
Includes (a) 15,933 restricted stock units that vest annually in equal installments on March 23, 2027 and March 23, 2028; and (b) 25,900 restricted stock units that vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029. This option is fully vested and exercisable.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 600
- Price
- $36.02
- Value
- $21,613
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 1,530
- Price
- $35.23
- Value
- $53,897
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 2,531
- Price
- $34.58
- Value
- $87,519
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 739
- Price
- $34.06
- Value
- $25,170
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 4,800
- Price
- $32.44
- Value
- $155,692
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 4,800
- Price
- $30.07
- Value
- $144,351
Jordan Julie
Chief Medical Officer
Sale 10b5-1
- Shares
- 828
- Price
- $21.89
- Value
- $18,128
McMinn Rachel
Chief Executive Officer
Sale 10b5-1
- Shares
- 3,352
- Price
- $22.07
- Value
- $73,995
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 2,558
- Price
- $21.62
- Value
- $55,316
Cobb Stuart
Chief Scientific Officer
Sale 10b5-1
- Shares
- 148
- Price
- $22.08
- Value
- $3,268
Cobb Stuart
Chief Scientific Officer
Sale 10b5-1
- Shares
- 2,658
- Price
- $21.34
- Value
- $56,722
Cobb Stuart
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,991
- Price
- $20.41
- Value
- $81,456
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 263
- Price
- $22.02
- Value
- $5,791
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 1,395
- Price
- $21.25
- Value
- $29,637
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 2,387
- Price
- $20.42
- Value
- $48,748
Cvijic Christine Mikail
President and CFO
Sale 10b5-1
- Shares
- 4,800
- Price
- $25.11
- Value
- $120,526
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 07, 2026 | Cvijic Christine Mikail President and CFO | Sale | 4,200 | $36.13 | $151,763 | |
| Jul 06, 2026 | Cvijic Christine Mikail President and CFO | Sale | 600 | $36.02 | $21,613 | |
| Jul 02, 2026 | Cvijic Christine Mikail President and CFO | Sale | 1,530 | $35.23 | $53,897 | |
| Jul 02, 2026 | Cvijic Christine Mikail President and CFO | Sale | 2,531 | $34.58 | $87,519 | |
| Jul 01, 2026 | Cvijic Christine Mikail President and CFO | Sale | 739 | $34.06 | $25,170 | |
| May 06, 2026 | Cvijic Christine Mikail President and CFO | Sale | 4,800 | $32.44 | $155,692 | |
| May 06, 2026 | Cvijic Christine Mikail President and CFO | Sale | 4,800 | $30.07 | $144,351 | |
| Mar 26, 2026 | Jordan Julie Chief Medical Officer | Sale | 828 | $21.89 | $18,128 | |
| Mar 26, 2026 | McMinn Rachel Chief Executive Officer | Sale | 3,352 | $22.07 | $73,995 | |
| Mar 26, 2026 | Cvijic Christine Mikail President and CFO | Sale | 2,558 | $21.62 | $55,316 | |
| Mar 13, 2026 | Cobb Stuart Chief Scientific Officer | Sale | 148 | $22.08 | $3,268 | |
| Mar 13, 2026 | Cobb Stuart Chief Scientific Officer | Sale | 2,658 | $21.34 | $56,722 | |
| Mar 13, 2026 | Cobb Stuart Chief Scientific Officer | Sale | 3,991 | $20.41 | $81,456 | |
| Mar 13, 2026 | Cvijic Christine Mikail President and CFO | Sale | 263 | $22.02 | $5,791 | |
| Mar 13, 2026 | Cvijic Christine Mikail President and CFO | Sale | 1,395 | $21.25 | $29,637 | |
| Mar 13, 2026 | Cvijic Christine Mikail President and CFO | Sale | 2,387 | $20.42 | $48,748 | |
| Feb 27, 2026 | Cvijic Christine Mikail President and CFO | Sale | 4,800 | $25.11 | $120,526 |